AR and neoplasm: These data suggest that tumor-specific differences in the induction of full-length AR and ARsv may account for the differential impact of pre-receptor androgen suppression on tumor-growth inhibition, with the marked rise in ARV7 observed in LuCaP96 rendering it correspondingly less sensitive to ligand suppression by dutasteride.